Email Updates

Search form

You are here

POWER

Status
Ongoing
Phase
Demo Project
Objective

Assesses women’s preferences for using microbicides and PrEP through demonstration projects with strategic pilots of delivery strategies, first with oral PrEP. Project will characterize choice, uptake, early adherence and identify cost-effective delivery models, including assessment of repeat HIV testing, decision-making within partnerships, and the interface with reproductive health services.  

Prevention Option(s)
Microbicides
PrEP
Trial Sponsors
University of Washington ICRC, Carnegie Mellon University, DTHF, Harvard U., KEMRI, Massachusetts General Hospital, RTI, Wits RHI, USAID
July 2015
June 2020
Enrollment
3 000
16
Years
29
Years
Population
Women
Sites

Site(s) - South Africa

South Africa

Site(s) - Kenya

Kenya